From: Use of evidence-based pharmacotherapy after myocardial infarction in Estonia
Treatment combinations | Men (%) | Women (%) |
---|---|---|
BB, No. (%) | 176 (7.44) | 123 (7.41) |
ACE/ARB, No. (%) | 170 (7.19) | 145 (8.73) |
Statins, No. (%) | 17 (0.72) | 12 (0.72) |
BB & ACE/ARB, No. (%) | 602 (25.45) | 525 (31.63)** |
BB & statins, No. (%) | 130 (5.50) | 49 (2.95)** |
ACE/ARB and statins, No. (%) | 141 (5.96) | 63 (3.80)** |
BB & ACE/ARB & statins, No. (%) | 999 (42.24) | 647 (38.98) |
No drugs, No. (%) | 130 (5.50) | 96 (5.78) |
Total, No. (%) | 2365 (100.00) | 1660 (100.00) |